GSM gold starGSM Global
中文版 · Chinese

University of Pittsburgh-Led Study on November 11: All 98,590 Participants Carried at Least One Pharmacogene Variant, With Over 17,000 Novel Variants Found

Monday, November 16, 2026 · Technology · GSM News

A study led by a University of Pittsburgh team was published on November 11 in Science Translational Medicine. Using data from the National Institutes of Health All of Us Research Program, the researchers analyzed whole-genome and electronic health record data from 98,590 participants, examining 16 pharmacogenes known to affect drug effectiveness or toxicity.

Every participant carried at least one variant in one of the 16 genes, with a median of nine variants per person. The team identified more than 17,000 previously undescribed novel variants and reported frequencies of known medication-linked variants across multiple ancestry groups, including populations where those frequencies had not previously been estimated.

On medication exposure, 24.4 percent of participants had been prescribed at least one drug known to be affected by a variant they carried. Drugs mentioned in the paper include some selective serotonin reuptake inhibitor antidepressants, statins, some chemotherapy drugs, and the blood thinner clopidogrel, sold as Plavix.

The analysis was observational. It measured variant frequency and prescription exposure, and did not test whether participants actually experienced side effects or poor outcomes as a result. The All of Us program aims to collect data from one million Americans from diverse backgrounds.

Source: University of Pittsburgh

Published by GSM · USA (original Chinese edition)

Photo: Wikimedia Commons, File:DNA double helix horizontal.png — Author: Jerome Walker. Licensing: Public domain.

Latest in Technology